Arrowhead Research Corporation (NASDAQ: ARWR), a targeted therapeutics company, today announced that, through its Calando Pharmaceuticals subsidiary, it has completed enrollment of a phase 1b clinical ...

LOWELL — The Cambodian American Literary Arts Association is a new nonprofit organization in Lowell that educates and empowers the Cambodian and multicultural communities through the literary arts.

Calando recently proved systemic siRNA delivery and RNAi-mediated mRNA knockdown. Arrowhead Research has increased its ownership of majority-owned subsidiary Calando Pharmaceuticals through the ...

Calando Pharmaceuticals has announced that pre-clinical development of a second siRNA oncology therapeutic, CALAA-02, is underway. The intracellular target for CALAA-02 is HIF-2alpha, or Hypoxia ...

PASADENA, Calif.--(BUSINESS WIRE)-- Arrowhead Research Corporation (NASDAQ: ARWR), a nanomedicine company with development programs in oncology, obesity and regenerative medicine, today announced that ...

Calando Pharmaceuticals, Inc. has the issuance of U.S. Patent No. 7,427,605, entitled, “Inhibitors of ribonucleotide reductase subunit 2 and uses thereof.” The patent contains claims directed to ...